Growth Equity

Porsche sells its stake in Bugatti Rimac to focus on its core business, paving the way for Rimac Group and new investors to accelerate a new hypercar future.

With a major investment from FTV Capital, fintech firm Valitana is set to accelerate its AI-driven transformation of the complex structured credit world.

The fast-growing pizza franchise accelerates its national push into Kansas and Tennessee, leveraging a low-cost model and new tech to challenge industry giants.

Backed by strategic capital, a new venture led by healthcare veterans aims to close care gaps for Florida's families with a tech-driven, value-based model.

For the 5th straight year, WA's life sciences outpace job growth. See how AI leadership and strategic investment fuel its $43.4B economic impact.

Natus Sensory is bringing back the trusted Otometrics name to unify its hearing and balance portfolio, a strategic move with deep market implications.

With 40%+ revenue growth and a new franchise deal, this tech-first dog care brand is leveraging software and strategy to capture the booming pet market.

With a seasoned dealmaker at the helm, Elkedonia is advancing a first-in-class, non-hallucinogenic drug for depression targeting a novel protein.

The Chinese pharma giant's Q1 results reveal a successful pivot to innovation, with blockbuster deals and a strategic Nasdaq listing paving its global path.

Kensington Capital's sixth SPAC begins trading its warrants separately, signaling the next phase in its search for a high-growth automotive or AI company.

Harrington Discovery Institute opens its 2027 award call, offering millions in funding and expert support to turn academic research into life-saving medicines.

Australian GRC leader Protecht buys US-based VISO TRUST, integrating advanced AI to automate security and dominate the rapidly expanding risk management market.

A Japanese startup’s ultra-fast genome accelerator joins a national AI program, aiming to slash sequencing time and democratize advanced healthcare.

Singapore's aquatic education leader prices a complex public offering to fuel a pivot into new sports, facing investor scrutiny and a volatile stock history.

With $4M GTD, Americas Cardroom's High Five series is back, now featuring elite 'Highest Five' events to attract pros alongside its inclusive schedule.

American Uranium secures over 1,000 acres at its Lo Herma project, bolstering domestic uranium resources amid a global nuclear energy resurgence.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

With a successful $191M IPO, Alamar Biosciences is set to revolutionize diagnostics with its ultra-sensitive proteomics platforms.

BTG Pactual TIG is funneling billions into Latin American timber, blending high finance with ambitious climate and biodiversity goals. What's behind this green gold rush?

Deep-tech firm AHOY surpasses $100M ARR with its "Real-World AI," now seeking major funding to expand its sovereign AI for critical infrastructure.